A quantitative investigation of the water-solubilizing properties of branched oligoglycerols

European Journal of Organic Chemistry

Volumn , Issue 18, 2007, Pages 3003-3011

  Nemoto, Hisao ^a   Araki, Takaaki ^a   Kamiya, Masaki ^a   Kawamura, Tomoyuki ^a   Hino, Tomoaki ^b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b KINJO GAKUIN UNIVERSITY   (Japan)

Author keywords

Glycerols; Hydroxylation; Iminodiacetic acid; Oligomers; Solvolysis

Indexed keywords

EID: 34347334687     PISSN: 1434193X     EISSN: 10990690     Source Type: Journal    
DOI: 10.1002/ejoc.200601036     Document Type: Article

References (37)

1. a) N. A. Urbanetz, Eur. J. Pharm. Sci. 2006, 28, 67-76;
2. b) G. Muhrer, U. Meier, F. Fusaro, S. Albano, M. Mazzotti, Int. J. Pharm. 2006, 308, 69-83;
3. c) A. I. Rodriguez-Perez, C. Rodriguez-Tenreiro, C. Alvarez-Lorenzo, P. Taboada, A. Concheiro, J. J. Torres-Labandeira, J. Pharm. Sci. 2006, 95, 1751-1762;
4. d) J. Xue, L. Chen, L. Zhou, Z. Jia, Y. Wang, X. Zhu, D. Yan, J. Polym. Sci., Part B: Polym. Phys. 2006, 44, 2050-2057;
5. e) Y. He, S. H. Yalkowsky, Int. J. Pharm. 2006, 314, 15-20;
6. f) K. Kawakami, N. Oda, K. Miyoshi, T. Funaki, Y. Ida, Eur. J. Pharm. Sci. 2006, 28, 7-14;
7. g) A. Fahr, P. van Hoogevest, S. May, N. Bergstrand, M. L. S. Leigh, Eur. J. Pharm. Sci. 2005, 26, 251-265;
8. h) S. Prabhu, M. Ortega, C. Ma, Int. J. Pharm. 2005, 301, 209-216;
9. i) P. Kocbek, S. Baumgartner, J. Kristl, Int. J. Pharm. 2006, 312, 179-186;
10. j) B. Y. Shekunov, P. Chattopadhyay, J. Seitzinger, R. Huff, Pharm. Res. 2006, 23, 196-204.
11. C. G. Wermuth, J. de La Fontaine, Practice of Medicinal Chemistry, 2nd ed., Elsevier, Amsterdam, Boston, Heidelberg, London, New York, Oxford, Paris, San Diego, San Francisco, Singapore, Sydney, Tokyo, 2003, pp. 617-630.
12. a) Isolation: M. C. Wani, H. L. Talyor, M. E. Wall, P. Coggon, A. T. McPhail, J. Am. Chem. Soc. 1971, 93, 2325-2326;
13. b) anticancer activity: E. K. Rowinsky, L. A. Cazenave, R. C. Donehower, J. Natl. Cancer Inst. 1990, 82, 1247-1259;
14. c) anti-cancer activity: E. K. Rowensky, R. C. Donehower, N. Engl. J. Med. 1995, 332, 1004-1014;
15. d) water solubility: D. M. Vyas, H. Wong, A. R. Crosswell, A. M. Casazza, J. O. Mamber, S. W. Doyle, T. W. Knipe, Bioorg. Med. Chem. Lett. 1993, 3, 1357-1360.
16. A. Battaglia, C. Bertucci, E. Bombardelli, S. Cimitan, A. Guerrini, P. Morazzoni, A. Riva, Eur. J. Med. Chem. 2003, 38, 383-389.
17. R. B. Greenwald, C. W. Gilbert, A. Pendri, C. D. Conover, J. Xia, A. Martinez, J. Med. Chem. 1996, 39, 424-431.
18. T. Mandai, T. Okumoto, H. Oshitari, K. Nakanishi, K. Mikuni, K.-J. Hara, K.-Z. Hara, W. Iwatani, T. Amano, K. Nakamura, Y. Tsuchiya, Heterocycles 2001, 54, 561-566.
19. Synthesis of various other oligomers of glycerol have been described: S. Cassel, C. Debaig, T. Benvegnu, P. Chaimbault, M. Lafosse, D. Plusquellec, P. Rollin, Eur. J. Org. Chem. 2001, 875-896.
20. Although no evaluation of water solubilization has been performed, the synthesis of dendrimers consisting of symmetrically linked glycerols or serinols assembled via linkers has been demonstrated: a) M. Jayaraman, J. M. J. Fréchet, J. Am. Chem. Soc. 1998, 120, 12996-12997;
21. b) M. A. Carnahan, M. W. Grinstaff, J. Am. Chem. Soc. 2001, 123, 2905-2906;
22. c) Y. A. Wang, J. J. Li, H. Chen, X. Peng, J. Am. Chem. Soc. 2002, 124, 2293-2298.
23. For our first papers on branched glycerols, see: a) H. Nemoto, J. G. Wilson, H. Nakamura, Y. Yamamoto, J. Org. Chem. 1992, 57, 435;
24. b) H. Nemoto, J. G. Wilson, H. Nakamura, Y. Yamamoto, J. Org. Chem. 1995, 60, 1478.
25. Y. Yamamoto, J. Cai, H. Nakamura, N. Sadayori, N. Asao, H. Nemoto, J. Org. Chem. 1995, 60, 3352-3357.
26. H. Nemoto, J. Cai, Y. Yamamoto, J. Chem. Soc., Chem. Commun. 1994, 577-578.
27. Y. Yamamoto, N. Asao, M. Meguro, N. Tsukada, H. Nemoto, N. Sadayori, J. G. Wilson, J. Chem. Soc., Chem. Commun. 1993, 1201-1203.
28. H. Nemoto, S. Iwamoto, H. Nakamura, Y. Yamamoto, Chem. Lett. 1993, 465-468.
29. For the preparation of p-boronophenylalanine, see: M. F. Hawthorn, Angew. Chem. Int. Ed. Engl. 1993, 32, 950-984.
30. H. Nemoto, J. Cai, S. Iwamoto, Y. Yamamoto, J. Med. Chem. 1995, 38, 1673-1678.
31. M. Takagaki, K. Ono, Y. Oda, H. Kikuchi, H. Nemoto, S. Iwamoto, J. Cai, Y. Yamamoto, Cancer Res. 1996, 56, 2017-2020.
32. H. Nemoto, J. Kikuishi, S. Yanagida, T. Kawano, M. Yamada, H. Harashima, H. Kiwada, M. Shibuya, Bioorg. Med. Chem. Lett. 1999, 9, 205-208.
33. [7]
34. The use of an octaarginine moiety for both water solubility and membrane permeation has been reported: L. R. Jones, E. A. Goun, R. Shinde, J. B. Rothbard, C. H. Contag, P. A. Wender, J. Am. Chem. Soc. 2006, 128, 6526-6527.
35. When compounds more polar than 8 were modified with various BGL-modified agents, a saturated aqueous solution of the corresponding tetraol or octaol derivatives could not be prepared (too water-soluble). When compounds less polar than 8 were modified similarly, the water solubility of the corresponding monool or diol derivatives could not reproducibly be measured. This is the reason why 8 was chosen.
36. F. Zaragoza-Dörwald, G. Von Kiedrowski. Synthesis 1988, 917-918.
37. Although the preparation of an octabenzyl ether consisting of seven glycerol units has been attempted, we have yet to succeed in its synthesis. Therefore octabenzyl ether 14a′, which consists of six glycerol units and one iminodiacetic acid unit, was synthesized instead. (Chemical Equation Presented)